UK Companies Report Key Trading and Financial Updates

Download IPFS

Manchester-based Genedrive PLC, a point-of-care pharmacogenetic testing company, addressed recent share price movements, noting discussions on a share chat platform that may have influenced sentiment. The company did not confirm a direct causal link between the posts and the share decline. It referred to communications between a member of staff at the National Institute for Health and Care Excellence (NICE) and a member of the public. Genedrive clarified that the communication referred to services provided by NHS Genomic Services for laboratory genomic testing, not point-of-care technologies. The company is actively reviewing its funding position and remains aware of the NHSE CYP2C19 pilot assessing rapid genetic testing for stroke patients. While interim assessments are positive, Genedrive confirmed no official publication date has been provided by NHSE.

Bezant Resources PLC, which explores copper and gold in Africa, South America, and the Philippines, has agreed to acquire a 90% stake in Namib Lead and Zinc Mining Ltd from CL US Minerals LLC. NLZM operates an ore processing plant, which will process copper-gold ore from Bezant’s Hope and Gorob projects using dry ore sorting technology. The company will pay $2.5 million on completion, alongside royalty payments based on processing output. Discussions are ongoing regarding financing options, including debt, equity, or prepaid finance, to support project development.

Oracle Power PLC, with projects in Western Australia and Pakistan, raised £500,000 through a share placing at 0.014 pence per share. The funds will advance project development in both regions and support general working capital. CEO Naheed Memon stated the fundraise would accelerate ongoing activities and provide further market updates in due course.

SkinBioTherapeutics PLC, focused on skin health, expects annual revenue for the year ending June 30 between £4.5 million and £4.8 million, up from £1.2 million previously, slightly below market forecasts due to order timing. EBITDA losses are expected between £200,000 and £400,000, an improvement from £2.2 million last year. Post-year-end July trading showed strong orders, particularly for the BTS business.

Sancus Lending Group Ltd, a London-based alternative finance provider, reported a 29% revenue increase to £9.7 million for the six months to June, up from £7.5 million. New loan facilities rose 54% to £78.6 million. Assets under management reached £259 million, an 8.8% increase. The group expects a pre-tax profit of £100,000, recovering from a £600,000 loss last year, supported by growth and credit management. Sancus also secured a £20 million funding facility from Paragon Bank PLC.

Calnex Solutions PLC in Linlithgow, Scotland, expects financial 2026 performance to meet market expectations. The company highlighted growth in cloud and defence markets and noted stability in telecoms activity.

Tirupati Graphite PLC, based in London, completed commissioning of its fourth primary concentrator unit at the BK6 mine in Madagascar. July production was reported at 221,000 tonnes of sellable graphite and was affected by unseasonal rainfall. Full production targets are expected by December 2025, with the company exploring additional funding options.

OptiBiotix Health PLC, in York, announced the inclusion of its SlimBiome appetite-reducing product in Hydroxycut, a popular US weight management brand, generating orders of nearly five metric tonnes for 2025 and offering growth potential.